Powering research advances

Across the country and worldwide, top scientists are working to solve the many parts of the type 1 diabetes (T1D) puzzle to deliver cures and life-improving breakthroughs. Breakthrough T1D helps fund their work, connects their research, and propels advances forward with the aim of getting solutions to the market as quickly as possible.

In some places, the research underway is so deep and so rich that it warrants special focus. It is here that we are launching Breakthrough T1D Centers of Excellence.

These Centers are a new research model charged with accelerating T1D science: improving lives and cures.

Distinctive, dynamic, and designed to accelerate

Selected for specialized excellence

Each Breakthrough T1D Center builds on an established depth of T1D excellence that has been sharpened and expanded by world-class leaders focusing on key research areas, such as immunology, stem cell biology, gene editing, and complications. Breakthrough T1D will link the Centers to each other and to ongoing research around the world to ensure maximum collaboration.

Designed for speed

Breakthrough T1D Centers are designed to foster highly dynamic, nimble work that will drive discovery with maximum speed. By providing researchers with long-term funding, we are removing the red tape, restrictions, and reporting that accompany standard research grants. This allows scientists to focus on research and gives them the freedom to quickly change paths to pursue alternate, promising directions without worrying about lost funding or filing new applications.

Leveraging resources and collaborations toward advances

These Centers will bring together experts from diverse fields and multiple institutions, as well as recruit new talents, to accelerate T1D advances. They will create a new fundraising model helping to maximize resources and link research efforts.

New England

Bringing together the expertise of multiple institutions to accelerate gene-modification approaches for beta cell replacement therapy.

Northern California

A collaboration between diabetes researchers at the University of California, San Francisco (UCSF), and Stanford University School of Medicine.

University of Michigan

Partnering with the Elizabeth Weiser Caswell Diabetes Institute at the institution to pursue T1D cures and reduce disease burden through improved treatments.


Bringing together experts from seven countries to improve health outcomes of people with T1D, accelerating the translation of research breakthroughs from bench to bedside.

University of British Columbia (UBC)

Uniting the expertise of global research leaders and partnerships in industry, health care, government, and academia towards a singular goal: curing T1D.